Status:
RECRUITING
Effectiveness of the Evaluation and Communication of "Pulmonary Age" as Help for Smoking Cessation
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Smoking Cessation
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
The experimental design is a cluster randomized trial in 2 parallel groups: an intervention group with assessment of the pulmonary age and a control group without. The population studied is patients ...
Detailed Description
Few scientific studies evaluate the pharmacological and non-pharmacological measurement of pulmonary age for smoking cessation. Moreover, existing research studies provide contradictory results. DESC...
Eligibility Criteria
Inclusion
- Patient 25 years of age or older
- Smoker for a year or more
- Patient giving informed and written consent to participate in the study
- Patient affiliated to a social security scheme
Exclusion
- Known respiratory illness, chronic or acute in progress or less than 3 weeks old (BPCO, asthma, other respiratory disease
- Refusal
- Myocardial infarction less than a year
- Chest or abdominal pain preventing or limiting completion of the forced exhalation maneuver necessary for evaluation of "pulmonary age", whatever the cause
- Oral or facial pain exacerbated by the mouthing of the mouthpiece
- Stress urinary incontinence
- Mental confusion or dementia
- Pregnant or breastfeeding woman
- Major protected
- Do not understand french
Key Trial Info
Start Date :
October 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04276116
Start Date
October 27 2023
End Date
March 1 2026
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint Antoine
Paris, France, 75012